You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Idamycin

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Sep 18, 2023

Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    Long Zhao
Apr 24, 2022

Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Idarubicin, Omacetaxine mepesuccinate)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University of Illinois at Chicago
Jul 1, 2021

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

Suspended
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Los Angeles, California
  • +5 more
Dec 10, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Birmingham, Alabama
  • +8 more
Jan 24, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Clofarabine 40mg/m^2
  • +5 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 3, 2020

Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Nivolumab, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 9, 2021

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Acute Myeloid Leukemia Trial in United States (CX-01, Idarubicin, Cytarabine)

Completed
Has Results
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +22 more
Sep 30, 2021

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia-2, High Risk Myelodysplastic Syndrome Trial in New Haven, Baltimore,

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • New Haven, Connecticut
  • +2 more
Oct 10, 2020

Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 17, 2020

Leukemia, Myeloid, Acute Trial (HDM201, cytarabine, anthracycline)

Withdrawn
  • Leukemia, Myeloid, Acute
  • (no location specified)
Jan 6, 2020

Leukemia Trial in Houston (LY2510924, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 14, 2019

Leukemia Trial in Houston (Decitabine, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 28, 2019

Acute Promyelocytic Leukemia Trial in Houston (All-Trans Retinoic Acid (ATRA), Arsenic Trioxide (ATO), Idarubicin)

Completed
Has Results
  • Acute Promyelocytic Leukemia
  • All-Trans Retinoic Acid (ATRA)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2019

Leukemia Trial in Houston (drug, radiation, biological)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 22, 2019

Acute Myeloid Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 10, 2018

Leukemia, Acute Myeloid Leukemia, AML Trial in Houston (Cytarabine, Idarubicin)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 23, 2018

Lymphoma Trial in Houston (biological, drug, procedure, radiation)

Completed
  • Lymphoma
  • Bleomycin Sulfate (BLM)
  • +17 more
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
Nov 13, 2018

AML, Acute Myeloid Leukemia, Myelodysplastic Disorders Trial in Houston (Idarubicin, Sorafenib, Ara-C)

Completed
Has Results
  • AML
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Jul 23, 2018

Leukemia Trial in Houston (E7070, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 4, 2018

Acute Myeloid Leukemia Trial (Dasatinib, Fludarabine, Cytarabine)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
Apr 17, 2018

AML Trial in Boston (Volasertib, Cytarabine, Idarubicin)

Withdrawn
  • AML
  • Boston, Massachusetts
  • +1 more
May 3, 2018